Plasenta Previa Olgularının Retrospektif Değerlendirilmesi: İkinci Basamak Hastane Deneyimi

Amaç: Bu çalışmanın amacı, hastanemizde tedavi edilen plasenta previa olgularının maternal ve neonatal sonuçlarını incelemektir. Materyal ve Metot: 2011-2016 yılları arasında doğumu gerçekleştirilen 107 plasenta previa vakasının kayıtları retrospektif olarak incelendi. Yaş, gravida, parite, eritrosit (RBC)-taze donmuş plazma (TDP) transfüzyonu gereksinimi, doğumdaki gebelik haftası, yenidoğanın doğum ağırlığı, 1. ve 5. dakika Apgar skoru, ek cerrahi girişim gereksinimi (internal iliak arter ligasyonu [İİAL], peripartum histerektomi) ve maternal komplikasyonlar değerlendirildi. Bulgular: RBC-TDP transfüzyonu ve İİAL oranları komplet plasenta previa olgularında parsiyel plasenta previa olgularına göre anlamlı olarak daha yüksekti. RBC-TDP transfüzyonu, İİAL ve peripartum histerektomi oranları plasenta akreata spektrumu (PAS) olgularında normal plasental invazyonu olan olgulara göre anlamlı olarak daha yüksekti. Tüm plasenta previa alt gruplarında prematürite riski artmıştı. Sonuç: Plasenta previa ile komplike olan gebeliklerin, özellikle eşlik eden plasenta invazyon anomalisi mevcutsa, olumsuz maternal ve neonatal sonuçlara neden olma riski artmaktadır.

RETROSPECTIVE EVALUATION OF PLACENTA PREVIA CASES: A SECONDARY-CENTER EXPERIENCE

Aim: This study aimed to evaluate the maternal and neonatal outcomes of placenta previa cases managed in our hospital.Materials and Methods: The records of 107 placenta previa cases delivered between 2011 and 2016 were retrospectively reviewed.Age, gravida, parity, red blood cell (RBC)-fresh frozen plasma (FFP) transfusion necessity, the gestational week at birth, birth weight, 1stand 5th minute Apgar score, the number of previous cesarean sections, requiring additional surgical intervention (internal iliac arteryligation [IIAL], peripartum hysterectomy) and maternal complications were examined.Results: RBC-FFP transfusion and IIAL rates were significantly higher in complete placenta previa cases than the partial placenta previacases. RBC-TDP transfusion, IIAL and peripartum hysterectomy rates were significantly higher in placenta accreata spectrum (PAS)cases compared to those cases with normal placental invasion. Prematurity risk increased in all placenta previa subgroups.Conclusion: Pregnancy complicated by placenta previa increases the risk of adverse maternal and neonatal outcomes, especially ifthere is concurrent placental invasion anomaly.

PDF

___

1. Durukan H, Durukan ÖB, Yazıcı FG. Planned versus urgent deliveries in placenta previa: maternal, surgical and neonatal results. Arch Gynecol Obstet. 2019;
2. Kollmann M, Gaulhofer J, Lang U, Klaritsch P. Placenta previa: incidence, risk factors and outcome. J Matern Fetal Neonatal Med. 2016;29(9):1395-8.
3. Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreata, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6.
4. Matalliotakis M, Velegrakis A, Goulielmos GN, Niraki E, Patelarou AE, Matalliotakis I. Association of Placenta Previa with a History of Previous Cesarean Deliveries and Indications for a Possible Role of a Genetic Component. Balkan J Med Genet. 2017;20(2):5-10.
5. Karami M, Jenabi E, Fereidooni B. The association of placenta previa and assisted reproductive techniques: a metaanalysis. J Matern Fetal Neonatal Med. 2018;31(14):1940-47.
6. Rosenberg T, Pariente G, Sergienko R, Wiznitzer A, Sheiner E. Critical analysis of risk factors and outcome of placenta previa. Arch Gynecol Obstet. 2011;284(1):47-51.
7. Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, et al. Placenta previa and Placenta Accreata: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019;126(1):e1-e48.
8. Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreata spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274-80.
9. Roustaei Z, Vehvilӓinen-Julkunen K, Tuomainen TP, Lamminpӓӓ R, Heinonen S. The effect of advanced maternal age on maternal and neonatal outcomes of placenta previa: A register-based cohort study. Eur J Obstet Gynecol Reprod Biol. 2018;227:1-7.
10. Porreco RP, Stettler RW. Surgical remedies for postpartum hemorrhage. Clin Obstet Gynecol. 2010;53(1):182-95.
11. Yildiz C, Akkar OB, Karakuş S, Çetin A, Yanik A. Hypogastric artery ligation for obstetrical hemorrhage: clinical experience in a tertiary care center. Turk J Med Sci. 2015;45(6):1312-6.
12. Rauf M, Ebru C, Sevil E, Selim B. Conservative management of post-partum hemorrhage secondary to placenta previaaccreata with hypogastric artery ligation and endo-uterine hemostatic suture. J Obstet Gynaecol Res. 2017;43(2):265-71.
13. Lal AK, Hibbard JU. Placenta previa: an outcome-based cohort study in a contemporary obstetric population. Arch Gynecol Obstet. 2015;292(2):299-305.
14. Sparić R, Mirković L, Ravilić U, Janjić T. Obstetric complications of placenta previa percreata. Vojnosanit Pregl. 2014;71(12):1163-6.
15. Ahmed SR, Aitallah A, Abdelghafar HM, Alsammani MA. Major Placenta Previa: Rate, Maternal and Neonatal Outcomes Experience at a Tertiary Maternity Hospital, Sohag, Egypt: A Prospective Study. J Clin Diagn Res. 2015;9(11):QC17-9.
16. Su HW, Yi YC, Tseng JJ, Chen WC, Chen YF, Kung HF, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353-357.
17. Tahaoglu AE, Balsak D, Togrul C, Obut M, Tosun O, Cavus Y, et al. Emergency peripartum hysterectomy: our experience. Ir J Med Sci. 2016;185(4):833-838.